Find your path to Leslie
97 people in our graph share verified history with Leslie — schools, employers, funds. One of them is your warm intro.
Carlos PayaunlockedLeslie: together at Elan Pharmaceuticals (2008–2011)
×5Leslie: together at Elan Pharmaceuticals
Leslie: together at Onyx Pharmaceuticals, Inc. (acquired by Amgen)
×4Leslie: together at Chiron Corporation
SVP, Intellectual Property at CytomX
Intro paths
→
In turn, Leslie can intro founders to CytomX's investors below.
Experience
- CytomX TherapeuticsSenior Vice President, Intellectual Propertycurrent2019 — presentSouth San Francisco, CA
- Coherus BioSciencesVice President, Intellectual Property2014 — 2019Redwood Shores, CA
- Onyx Pharmaceuticals, Inc. (acquired by Amgen)Associate Intellectual Property Counsel2012 — 2013South San Francisco, CA
- Elan PharmaceuticalsSenior Director, Intellectual Property2001 — 2011South San Francisco, CA
- Burns Doane Swecker & MathisAssociate Attorney1996 — 2001Redwood Shores, CA
- Chiron CorporationResearch Associate1990 — 1992Emeryville, CA
Skills & more
Intellectual PropertyBiotechnologyBiosimilarsBPCIALicensingMergers & AcquisitionsPatentsBiologicsProsecutionPatent ProsecutionPharmaceutical IndustryDue Diligence
+7 more
LifesciencesTechnology TransferPatent preparationBiopharmaceuticalsTrade SecretsOncologyCommercialization- License to Practice Law in California — State Bar of California
- Registered Patent Attorney — USPTO
From Leslie's professional profile.
Frequently asked questions
- Who is Leslie Robbins?
- SVP, Intellectual Property at CytomX
- Where does Leslie Robbins work?
- Leslie Robbins is SVP, Intellectual Property at CytomX.
- Where did Leslie Robbins go to school?
- Leslie Robbins studied at University of California, Berkeley (BA, Microbiology and Immunology); Chicago-Kent College of Law, Illinois Institute of Technology (Juris Doctor).
Same school
Also attended University of California, Berkeley2,000
Steve WozniakCo-founder of AppleAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksAbraham BachrachCo-founder & CTO of SkydioTrevor OelschigInvestment Team at General CatalystAnthony LinHead of Intel Capital, Corporate Vice President at Intel Capital
+ 1,994 more
Also attended Chicago-Kent College of Law, Illinois Institute of Technology16
Dawid KsiążczakChief Legal Officer at McWin Capital PartnersDaniel FugmannGeneral Counsel at North-East Family OfficeDavid BamlangoGroup Vice President, Deputy Managing Director & General Counsel at Trade and Development BankSamer YaghnamChief Operations Officer at The Olayan GroupBrian CrumpPrincipal at Chicago Early Growth Ventures (CEGV)Theodore KoenigPresident at Monroe Capital
+ 10 more
Shared employers
Also worked at CytomX Therapeutics12
Bryan A. IrvingSenior Advisor at Frazier Life SciencesCharles (Charlie) FuchsSenior Advisor at Frazier Life SciencesKrishna PoluPrincipal at Red Tree VentureJeff LandauChief Executive Officer at Stipple BioRoland GendronChief Business Officer at Stipple BioRachel HumphreyFounding Chief Executive Officer at Normunity
+ 6 more
Also worked at Coherus BioSciences7
Lee NewcomerAdvisor at Oncology VenturesHenry HiemstraAssociate at 137 VenturesElona BaumManaging Director at DEFTA PartnersDenny LanfearFounder at Coherus BiosciencesJonathan HillEntrepreneur-In-Residence at RA CapitalJim HassardEVP, Chief Commercial Officer at Aligos Therapeutics
+ 1 more
Also worked at Onyx Pharmaceuticals, Inc. (acquired by Amgen)24
Justin KaoPartner at DFJMattInvestor at Bungalow CapitalChris PeetzEntrepreneur-in-Residence at Frazier Life SciencesJohn OsbornVenture Partner and Principal at Bioventures InvestorsKristin Baker SpohnGeneral Partner at CRV (Charles River Ventures)Luigi CostaInvestor at Pureos Bioventures
+ 18 more
Also worked at Elan Pharmaceuticals22
Carlos PayaVenture Partner at Ysios CapitalLars EkmanExecutive Partner, Private Equity at Sofinnova VenturesDeclan KellyCFO at Delta PartnersDaniel O'MahonyPartner at Seroba Life SciencesAlan O'ConnellPartner at Seroba Life SciencesGeorge GolumbeskiPartner at Droia Ventures
+ 16 more